Indaptus Therapeutics extends deadline for $24 million private placement closing to Oct. 16
INDP•Indaptus Therapeutics extended the closing deadline for its private placement of common stock, expected to raise about $24 million, to Oct. 16, 2026, from Sept. 29. Purchasers’ funding deadline and related termination rights were also extended to Oct. 16.
1. Closing deadline extended
Indaptus Therapeutics extended the deadline under its stock purchase agreement for a private placement of common stock, which is expected to generate gross proceeds of about $24 million, from Sept. 29 to Oct. 16, 2026. Purchasers’ funding deadline and related termination rights were also extended to Oct. 16. The company may defer or coordinate closings across purchasers, subject to conditions, but not beyond the extended deadline.
